
浏览全部资源
扫码关注微信
纸质出版日期:2014
移动端阅览
范辉, 仝淼, 王晓峰. 芪红解郁方治疗慢性心力衰竭合并抑郁症患者60例[J]. 中国实验方剂学杂志, 2014,20(18):208-211.
FAN Hui, TONG Miao, WANG Xiao-feng. Effect of Qihong Jieyu Decoction Treatment on 60 Patients with Depression Secondary to Chronic Heart Failure[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(18): 208-211.
范辉, 仝淼, 王晓峰. 芪红解郁方治疗慢性心力衰竭合并抑郁症患者60例[J]. 中国实验方剂学杂志, 2014,20(18):208-211. DOI: 10.13422/j.cnki.syfjx.2014180208.
FAN Hui, TONG Miao, WANG Xiao-feng. Effect of Qihong Jieyu Decoction Treatment on 60 Patients with Depression Secondary to Chronic Heart Failure[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(18): 208-211. DOI: 10.13422/j.cnki.syfjx.2014180208.
目的: 探讨芪红解郁方治疗慢性心力衰竭合并抑郁症患者的近期疗效及对N末端B型利钠肽原(NT-proBNP)的影响。方法: 将120例慢性心力衰竭合并抑郁症患者采用随机按住院前后分为对照组和观察组各60例。两组均给予西医常规抗心衰治疗,对照组服用帕罗西汀。观察组服用芪红解郁方,1剂/d。两组疗程均为8周,并进行6个月随访。进行治疗前后Lee氏心衰评分、汉密尔顿抑郁量表(HAMD)、抑郁自评量表(SDS)和明尼苏达心衰生活质量调查表(MLHFQ)评分;测量治疗前后左心室射血分数(LVEF)和心输出量(CO);随访6个月内患者再入院情况;检测治疗前后NT-proBNP水平;记录两组观察期间不良反应。结果: 观察组临床Lee氏心衰疗效总有效率为86.67%,优于对照组的71.67%(P<0.05);观察组临床抑郁症疗效总有效率88.33%,对照组为81.67%,组间比较差异无统计学意义;治疗后观察组Lee氏心衰评分、HAMD,SDS和MLHFQ评分均低于对照组(P<0.01);观察组LVEF和CO高于对照组(P<0.01);观察组NT-proBNP水平低于对照组(P<0.01);对照组不良反应发生率高达58.3%,观察组未发现明显不良反应;在6个月随访期内观察组再入院率为36.66%,低于对照组的61.66%(P<0.05)。结论: 芪红解郁方对慢性心力衰竭合并抑郁症患者的心衰和抑郁症状均有明显改善作用,能提高患者生活质量,降低再入院率,疗效确切且副作用低。
Objective: To observe short-term curative effect of Qihong Jieyu decoction and changes of N-terminal pro-brain natriuretic peptide (NT-proBNP) on patients with depression secondary to chronic heart failure. Method: One hundred and twenty patients with depression secondary to chronic heart failure were randomly divided into control group and observation group (60 cases
respectively) according to order of hospitalization. Patients in both groups' receive routine western medicine treatment of congestive heart failure. Patients in control group received paroxetine. Patients in observation group received Qihong Jieyu decoction
1 dose per day. Treatment in both groups continued to 8 weeks and a 6-month follow-up was made at the end of treatment. Scores of Clinical Lee's heart failure
Hamilton's depression scale(HAMD)
self-rating depression scale(SDS) and Minnesota heart failure quality of life questionnaire(MLHFQ) were made before and after treatment. Left ventricular ejection fraction(LVEF) and cardiac output(CO) were measured. Condition of re-hospitalization was recorded during the 6-month follow-up. And level of NT-proBNP was also detected. Adverse reaction were also recorded during the observation period. Result: The total curative efficacy of Clinical Lee's heart failure in observation group was 86.67% and that in control group was 71.67%
the difference was significant (P<0.05). And the total curative efficacy of clinical depression in observation group was 88.33%
higher than that in control group 81.67%
however there was no significant differences between two groups. Scores of Lee's heart failure
HAMD
SDS and MLHFQ in observation group were lower than those in control group (P<0.01). LVEF and CO in observation group were higher than those in control group (P<0.01). Level of NT-proBNP was lower than that in control group (P<0.01).Occurrence rate of adverse reaction in control group was 58.3%
and there was no adverse reaction in observation group. During the 6 mouths' follow-up visit
rate of re-hospitalization in observation group was 36.66%
which is lower than 61.66% in control group (P<0.05). Conclusion: Qihong Jieyu decoction can significantly ameliorate symptoms of heart failure and depression of patients with depression secondary to chronic heart failure
improve patients' qualities of lives
lower rate of re-hospitalization
and there is a definite curative effects and lower adverse reaction.
0
浏览量
4
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621